Ocular Therapeutix™ To Report Third Quarter 2019 Financial Results

BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will report second quarter ended September 30, 2019 financial results on Tuesday, November 12, 2019. Following distribution of the earnings release via wire services, the Ocular Therapeutix management team will host a live conference call and we

Full Story →